PKN2_HUMAN - dbPTM
PKN2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PKN2_HUMAN
UniProt AC Q16513
Protein Name Serine/threonine-protein kinase N2
Gene Name PKN2
Organism Homo sapiens (Human).
Sequence Length 984
Subcellular Localization Cytoplasm . Nucleus . Membrane . Cell projection, lamellipodium . Cytoplasm, cytoskeleton . Cleavage furrow . Midbody . Cell junction . Colocalizes with PTPN13 in lamellipodia-like structures, regions of large actin turnover. Accumulates during telop
Protein Description PKC-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. Plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and hence decreases CTTN ability to associate with filamentous actin. Phosphorylates HDAC5, therefore lead to impair HDAC5 import. Direct RhoA target required for the regulation of the maturation of primordial junctions into apical junction formation in bronchial epithelial cells. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Stimulates FYN kinase activity that is required for establishment of skin cell-cell adhesion during keratinocytes differentiation. Regulates epithelial bladder cells speed and direction of movement during cell migration and tumor cell invasion. Inhibits Akt pro-survival-induced kinase activity. Mediates Rho protein-induced transcriptional activation via the c-fos serum response factor (SRF). Phosphorylates HCV NS5B leading to stimulation of HCV RNA replication. Involved in the negative regulation of ciliogenesis. [PubMed: 27104747]
Protein Sequence MASNPERGEILLTELQGDSRSLPFSENVSAVQKLDFSDTMVQQKLDDIKDRIKREIRKELKIKEGAENLRKVTTDKKSLAYVDNILKKSNKKLEELHHKLQELNAHIVVSDPEDITDCPRTPDTPNNDPRCSTSNNRLKALQKQLDIELKVKQGAENMIQMYSNGSSKDRKLHGTAQQLLQDSKTKIEVIRMQILQAVQTNELAFDNAKPVISPLELRMEELRHHFRIEFAVAEGAKNVMKLLGSGKVTDRKALSEAQARFNESSQKLDLLKYSLEQRLNEVPKNHPKSRIIIEELSLVAASPTLSPRQSMISTQNQYSTLSKPAALTGTLEVRLMGCQDILENVPGRSKATSVALPGWSPSETRSSFMSRTSKSKSGSSRNLLKTDDLSNDVCAVLKLDNTVVGQTSWKPISNQSWDQKFTLELDRSRELEISVYWRDWRSLCAVKFLRLEDFLDNQRHGMCLYLEPQGTLFAEVTFFNPVIERRPKLQRQKKIFSKQQGKTFLRAPQMNINIATWGRLVRRAIPTVNHSGTFSPQAPVPTTVPVVDVRIPQLAPPASDSTVTKLDFDLEPEPPPAPPRASSLGEIDESSELRVLDIPGQDSETVFDIQNDRNSILPKSQSEYKPDTPQSGLEYSGIQELEDRRSQQRFQFNLQDFRCCAVLGRGHFGKVLLAEYKNTNEMFAIKALKKGDIVARDEVDSLMCEKRIFETVNSVRHPFLVNLFACFQTKEHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEHKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSTEAISIMRRLLRRNPERRLGASEKDAEDVKKHPFFRLIDWSALMDKKVKPPFIPTIRGREDVSNFDDEFTSEAPILTPPREPRILSEEEQEMFRDFDYIADWC
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MASNPERGE
------CCCCCCCCC
20.29-
3Phosphorylation-----MASNPERGEI
-----CCCCCCCCCE
52.1725159151
10 (in isoform 4)Phosphorylation-4.2122210691
21PhosphorylationELQGDSRSLPFSENV
EECCCCCCCCCCCCC
44.3330266825
25PhosphorylationDSRSLPFSENVSAVQ
CCCCCCCCCCCCHHE
26.7330266825
27UbiquitinationRSLPFSENVSAVQKL
CCCCCCCCCCHHEEC
31.6729967540
29PhosphorylationLPFSENVSAVQKLDF
CCCCCCCCHHEECCC
34.0125159151
39PhosphorylationQKLDFSDTMVQQKLD
EECCCCHHHHHHHHH
20.3128857561
40SulfoxidationKLDFSDTMVQQKLDD
ECCCCHHHHHHHHHH
2.8421406390
44UbiquitinationSDTMVQQKLDDIKDR
CHHHHHHHHHHHHHH
36.4732015554
58AcetylationRIKREIRKELKIKEG
HHHHHHHHHCCHHHH
73.417266301
59UbiquitinationIKREIRKELKIKEGA
HHHHHHHHCCHHHHH
45.5121963094
77AcetylationRKVTTDKKSLAYVDN
HHHCCCHHHHHHHHH
54.2125953088
77UbiquitinationRKVTTDKKSLAYVDN
HHHCCCHHHHHHHHH
54.2119413330
78PhosphorylationKVTTDKKSLAYVDNI
HHCCCHHHHHHHHHH
24.7928152594
81PhosphorylationTDKKSLAYVDNILKK
CCHHHHHHHHHHHHH
17.4028152594
84UbiquitinationKSLAYVDNILKKSNK
HHHHHHHHHHHHCCH
31.2929967540
90UbiquitinationDNILKKSNKKLEELH
HHHHHHCCHHHHHHH
55.1232015554
110PhosphorylationLNAHIVVSDPEDITD
HCCCEEECCHHHCCC
36.2330266825
110UbiquitinationLNAHIVVSDPEDITD
HCCCEEECCHHHCCC
36.2329967540
115UbiquitinationVVSDPEDITDCPRTP
EECCHHHCCCCCCCC
3.1432015554
116PhosphorylationVSDPEDITDCPRTPD
ECCHHHCCCCCCCCC
43.8230576142
118GlutathionylationDPEDITDCPRTPDTP
CHHHCCCCCCCCCCC
1.5122555962
121PhosphorylationDITDCPRTPDTPNND
HCCCCCCCCCCCCCC
15.6225159151
124PhosphorylationDCPRTPDTPNNDPRC
CCCCCCCCCCCCCCC
29.1725159151
127UbiquitinationRTPDTPNNDPRCSTS
CCCCCCCCCCCCCCC
62.9624816145
143UbiquitinationNRLKALQKQLDIELK
HHHHHHHHHHCCEEH
54.39-
162PhosphorylationAENMIQMYSNGSSKD
HHHHHHHHHCCCHHH
5.2120068231
163PhosphorylationENMIQMYSNGSSKDR
HHHHHHHHCCCHHHH
29.4025159151
166PhosphorylationIQMYSNGSSKDRKLH
HHHHHCCCHHHHHHH
38.1620068231
167PhosphorylationQMYSNGSSKDRKLHG
HHHHCCCHHHHHHHH
39.7225159151
171MalonylationNGSSKDRKLHGTAQQ
CCCHHHHHHHHHHHH
55.7726320211
171UbiquitinationNGSSKDRKLHGTAQQ
CCCHHHHHHHHHHHH
55.7729967540
183PhosphorylationAQQLLQDSKTKIEVI
HHHHHHCCCHHHHHH
29.3020873877
184UbiquitinationQQLLQDSKTKIEVIR
HHHHHCCCHHHHHHH
63.2329967540
193UbiquitinationKIEVIRMQILQAVQT
HHHHHHHHHHHHHHC
24.3229967540
228UbiquitinationELRHHFRIEFAVAEG
HHHHHHHHHHHHHHH
5.0921963094
239UbiquitinationVAEGAKNVMKLLGSG
HHHHHHHHHHHHCCC
3.3621963094
241UbiquitinationEGAKNVMKLLGSGKV
HHHHHHHHHHCCCCC
35.9629967540
247AcetylationMKLLGSGKVTDRKAL
HHHHCCCCCCCHHHH
43.5927452117
247UbiquitinationMKLLGSGKVTDRKAL
HHHHCCCCCCCHHHH
43.5932015554
253UbiquitinationGKVTDRKALSEAQAR
CCCCCHHHHHHHHHH
19.7429967540
255PhosphorylationVTDRKALSEAQARFN
CCCHHHHHHHHHHHH
35.4320068231
264PhosphorylationAQARFNESSQKLDLL
HHHHHHHHHHHHHHH
38.8920873877
265PhosphorylationQARFNESSQKLDLLK
HHHHHHHHHHHHHHH
25.7528857561
2672-HydroxyisobutyrylationRFNESSQKLDLLKYS
HHHHHHHHHHHHHHH
46.01-
267UbiquitinationRFNESSQKLDLLKYS
HHHHHHHHHHHHHHH
46.0129967540
272AcetylationSQKLDLLKYSLEQRL
HHHHHHHHHHHHHHH
39.8420167786
272UbiquitinationSQKLDLLKYSLEQRL
HHHHHHHHHHHHHHH
39.8432015554
273PhosphorylationQKLDLLKYSLEQRLN
HHHHHHHHHHHHHHH
20.6117494752
274PhosphorylationKLDLLKYSLEQRLNE
HHHHHHHHHHHHHHH
24.6817494752
284UbiquitinationQRLNEVPKNHPKSRI
HHHHHCCCCCCCCCE
73.4124816145
289PhosphorylationVPKNHPKSRIIIEEL
CCCCCCCCCEEEEEH
32.9120068231
297PhosphorylationRIIIEELSLVAASPT
CEEEEEHHHHHCCCC
24.8720873877
302PhosphorylationELSLVAASPTLSPRQ
EHHHHHCCCCCCHHH
14.5329255136
304PhosphorylationSLVAASPTLSPRQSM
HHHHCCCCCCHHHHH
37.0630266825
306PhosphorylationVAASPTLSPRQSMIS
HHCCCCCCHHHHHCC
22.1030266825
310PhosphorylationPTLSPRQSMISTQNQ
CCCCHHHHHCCCCCH
21.2630576142
313PhosphorylationSPRQSMISTQNQYST
CHHHHHCCCCCHHHC
18.4629449344
314PhosphorylationPRQSMISTQNQYSTL
HHHHHCCCCCHHHCC
22.1829449344
318PhosphorylationMISTQNQYSTLSKPA
HCCCCCHHHCCCCCC
15.9223917254
323UbiquitinationNQYSTLSKPAALTGT
CHHHCCCCCCHHCCC
41.61-
338GlutathionylationLEVRLMGCQDILENV
EEEEEECHHHHHHCC
1.7322555962
345UbiquitinationCQDILENVPGRSKAT
HHHHHHCCCCCCCCC
3.7732015554
349PhosphorylationLENVPGRSKATSVAL
HHCCCCCCCCCEEEC
32.34-
350UbiquitinationENVPGRSKATSVALP
HCCCCCCCCCEEECC
55.0829967540
352PhosphorylationVPGRSKATSVALPGW
CCCCCCCCEEECCCC
27.7223403867
353PhosphorylationPGRSKATSVALPGWS
CCCCCCCEEECCCCC
15.3923403867
360PhosphorylationSVALPGWSPSETRSS
EEECCCCCCHHHHHH
25.1819664994
360 (in isoform 2)Phosphorylation-25.1825159151
362PhosphorylationALPGWSPSETRSSFM
ECCCCCCHHHHHHHH
46.1925159151
362 (in isoform 2)Phosphorylation-46.1925159151
364PhosphorylationPGWSPSETRSSFMSR
CCCCCHHHHHHHHHC
39.9425159151
364 (in isoform 2)Phosphorylation-39.9425159151
366PhosphorylationWSPSETRSSFMSRTS
CCCHHHHHHHHHCCC
35.0325159151
366 (in isoform 2)Phosphorylation-35.0325159151
367PhosphorylationSPSETRSSFMSRTSK
CCHHHHHHHHHCCCC
22.9825159151
367 (in isoform 2)Phosphorylation-22.9825159151
370PhosphorylationETRSSFMSRTSKSKS
HHHHHHHHCCCCCCC
30.3225159151
370 (in isoform 2)Phosphorylation-30.3225159151
372PhosphorylationRSSFMSRTSKSKSGS
HHHHHHCCCCCCCCC
32.9529514088
373PhosphorylationSSFMSRTSKSKSGSS
HHHHHCCCCCCCCCC
33.5529514088
374UbiquitinationSFMSRTSKSKSGSSR
HHHHCCCCCCCCCCC
62.3829967540
375PhosphorylationFMSRTSKSKSGSSRN
HHHCCCCCCCCCCCC
31.6429038488
376MethylationMSRTSKSKSGSSRNL
HHCCCCCCCCCCCCC
63.67116252779
377PhosphorylationSRTSKSKSGSSRNLL
HCCCCCCCCCCCCCC
51.5029038488
379PhosphorylationTSKSKSGSSRNLLKT
CCCCCCCCCCCCCCC
32.9625159151
380PhosphorylationSKSKSGSSRNLLKTD
CCCCCCCCCCCCCCC
28.8129038488
385UbiquitinationGSSRNLLKTDDLSND
CCCCCCCCCCCCCCC
53.7421963094
394UbiquitinationDDLSNDVCAVLKLDN
CCCCCCEEEEEEECC
2.1229967540
402PhosphorylationAVLKLDNTVVGQTSW
EEEEECCCEEEEECC
19.0820873877
407PhosphorylationDNTVVGQTSWKPISN
CCCEEEEECCEECCC
30.5320873877
408PhosphorylationNTVVGQTSWKPISNQ
CCEEEEECCEECCCC
25.8020873877
408UbiquitinationNTVVGQTSWKPISNQ
CCEEEEECCEECCCC
25.8021963094
410UbiquitinationVVGQTSWKPISNQSW
EEEEECCEECCCCCC
32.0429967540
413PhosphorylationQTSWKPISNQSWDQK
EECCEECCCCCCCCE
37.0320873877
416PhosphorylationWKPISNQSWDQKFTL
CEECCCCCCCCEEEE
36.5520873877
426PhosphorylationQKFTLELDRSRELEI
CEEEEEECCCCEEEE
36.8132142685
428PhosphorylationFTLELDRSRELEISV
EEEEECCCCEEEEEE
29.7626091039
454UbiquitinationKFLRLEDFLDNQRHG
EEEEHHHHHHCCCCE
7.2432015554
458UbiquitinationLEDFLDNQRHGMCLY
HHHHHHCCCCEEEEE
38.1122817900
462UbiquitinationLDNQRHGMCLYLEPQ
HHCCCCEEEEEECCC
0.8629967540
468UbiquitinationGMCLYLEPQGTLFAE
EEEEEECCCCEEEEE
34.9929967540
486UbiquitinationFNPVIERRPKLQRQK
CCHHHHCCHHHHHHH
21.6632015554
497PhosphorylationQRQKKIFSKQQGKTF
HHHHHHHHHHCCCCH
32.7823401153
498UbiquitinationRQKKIFSKQQGKTFL
HHHHHHHHHCCCCHH
35.57-
501UbiquitinationKIFSKQQGKTFLRAP
HHHHHHCCCCHHCCC
28.6021963094
502UbiquitinationIFSKQQGKTFLRAPQ
HHHHHCCCCHHCCCC
31.5932015554
503PhosphorylationFSKQQGKTFLRAPQM
HHHHCCCCHHCCCCC
34.4227251275
503UbiquitinationFSKQQGKTFLRAPQM
HHHHCCCCHHCCCCC
34.4221963094
516PhosphorylationQMNINIATWGRLVRR
CCCEEHHHHHHHHHH
25.3430576142
517UbiquitinationMNINIATWGRLVRRA
CCEEHHHHHHHHHHH
4.8521963094
520UbiquitinationNIATWGRLVRRAIPT
EHHHHHHHHHHHCCC
2.8729967540
527PhosphorylationLVRRAIPTVNHSGTF
HHHHHCCCCCCCCCC
28.0328176443
531PhosphorylationAIPTVNHSGTFSPQA
HCCCCCCCCCCCCCC
34.0330266825
533PhosphorylationPTVNHSGTFSPQAPV
CCCCCCCCCCCCCCC
24.7730266825
535PhosphorylationVNHSGTFSPQAPVPT
CCCCCCCCCCCCCCC
18.8830266825
542PhosphorylationSPQAPVPTTVPVVDV
CCCCCCCCCCEEEEE
40.4324732914
543PhosphorylationPQAPVPTTVPVVDVR
CCCCCCCCCEEEEEE
19.4224732914
549UbiquitinationTTVPVVDVRIPQLAP
CCCEEEEEECCCCCC
3.9521963094
559PhosphorylationPQLAPPASDSTVTKL
CCCCCCCCCCCCEEE
37.5615822905
561PhosphorylationLAPPASDSTVTKLDF
CCCCCCCCCCEEECC
23.4515822905
562PhosphorylationAPPASDSTVTKLDFD
CCCCCCCCCEEECCC
36.8723828894
564PhosphorylationPASDSTVTKLDFDLE
CCCCCCCEEECCCCC
26.4426074081
565UbiquitinationASDSTVTKLDFDLEP
CCCCCCEEECCCCCC
41.5421963094
567PhosphorylationDSTVTKLDFDLEPEP
CCCCEEECCCCCCCC
36.2532142685
571UbiquitinationTKLDFDLEPEPPPAP
EEECCCCCCCCCCCC
49.8429967540
577UbiquitinationLEPEPPPAPPRASSL
CCCCCCCCCCCCCCC
32.2929967540
582PhosphorylationPPAPPRASSLGEIDE
CCCCCCCCCCCCCCC
27.6329255136
583PhosphorylationPAPPRASSLGEIDES
CCCCCCCCCCCCCCC
39.1329255136
590PhosphorylationSLGEIDESSELRVLD
CCCCCCCCCCEEEEE
25.9325159151
591PhosphorylationLGEIDESSELRVLDI
CCCCCCCCCEEEEEC
38.3123927012
603PhosphorylationLDIPGQDSETVFDIQ
EECCCCCCCEEEEEC
27.5520873877
603UbiquitinationLDIPGQDSETVFDIQ
EECCCCCCCEEEEEC
27.5529967540
604UbiquitinationDIPGQDSETVFDIQN
ECCCCCCCEEEEECC
58.2327667366
605PhosphorylationIPGQDSETVFDIQND
CCCCCCCEEEEECCC
30.3529978859
609UbiquitinationDSETVFDIQNDRNSI
CCCEEEEECCCCCCC
2.5429967540
613MethylationVFDIQNDRNSILPKS
EEEECCCCCCCCCCC
46.47115487703
615PhosphorylationDIQNDRNSILPKSQS
EECCCCCCCCCCCCC
26.7920068231
619UbiquitinationDRNSILPKSQSEYKP
CCCCCCCCCCCCCCC
58.6529967540
620PhosphorylationRNSILPKSQSEYKPD
CCCCCCCCCCCCCCC
36.6829978859
622PhosphorylationSILPKSQSEYKPDTP
CCCCCCCCCCCCCCC
50.4029978859
624PhosphorylationLPKSQSEYKPDTPQS
CCCCCCCCCCCCCCC
32.8228796482
625UbiquitinationPKSQSEYKPDTPQSG
CCCCCCCCCCCCCCC
32.1629967540
627UbiquitinationSQSEYKPDTPQSGLE
CCCCCCCCCCCCCCC
67.8622817900
628PhosphorylationQSEYKPDTPQSGLEY
CCCCCCCCCCCCCCC
31.5825159151
629UbiquitinationSEYKPDTPQSGLEYS
CCCCCCCCCCCCCCC
33.4529967540
631PhosphorylationYKPDTPQSGLEYSGI
CCCCCCCCCCCCCCC
46.6930175587
635PhosphorylationTPQSGLEYSGIQELE
CCCCCCCCCCCHHHH
19.7621712546
636PhosphorylationPQSGLEYSGIQELED
CCCCCCCCCCHHHHH
21.7521712546
646PhosphorylationQELEDRRSQQRFQFN
HHHHHHHHHHCCEEC
31.4030576142
658PhosphorylationQFNLQDFRCCAVLGR
EECCHHHHHHEEECC
23.9332142685
658UbiquitinationQFNLQDFRCCAVLGR
EECCHHHHHHEEECC
23.9329901268
659PhosphorylationFNLQDFRCCAVLGRG
ECCHHHHHHEEECCC
1.4432142685
661UbiquitinationLQDFRCCAVLGRGHF
CHHHHHHEEECCCCC
11.8229967540
663PhosphorylationDFRCCAVLGRGHFGK
HHHHHEEECCCCCHH
1.7432142685
676PhosphorylationGKVLLAEYKNTNEMF
HHHEEEECCCCCCCC
12.1628102081
677UbiquitinationKVLLAEYKNTNEMFA
HHEEEECCCCCCCCH
49.1229967540
686AcetylationTNEMFAIKALKKGDI
CCCCCHHHHHHHCCE
44.2119820183
690UbiquitinationFAIKALKKGDIVARD
CHHHHHHHCCEEEHH
63.7729901268
701PhosphorylationVARDEVDSLMCEKRI
EEHHHHHHHHHHHHH
24.1530576142
7062-HydroxyisobutyrylationVDSLMCEKRIFETVN
HHHHHHHHHHHHHHH
45.96-
706AcetylationVDSLMCEKRIFETVN
HHHHHHHHHHHHHHH
45.9626051181
706UbiquitinationVDSLMCEKRIFETVN
HHHHHHHHHHHHHHH
45.9629901268
720UbiquitinationNSVRHPFLVNLFACF
HHCCCCHHHHHHHHC
2.6922817900
722UbiquitinationVRHPFLVNLFACFQT
CCCCHHHHHHHHCCC
31.4322817900
729PhosphorylationNLFACFQTKEHVCFV
HHHHHCCCCCEEEEE
20.3924719451
736UbiquitinationTKEHVCFVMEYAAGG
CCCEEEEEEEECCCC
2.1122817900
767PhosphorylationVFYAACVVLGLQYLH
HHHHHHHHHHHHHHH
3.3632142685
768PhosphorylationFYAACVVLGLQYLHE
HHHHHHHHHHHHHHH
2.5632142685
768UbiquitinationFYAACVVLGLQYLHE
HHHHHHHHHHHHHHH
2.5622817900
771UbiquitinationACVVLGLQYLHEHKI
HHHHHHHHHHHHCCE
36.6229967540
772PhosphorylationCVVLGLQYLHEHKIV
HHHHHHHHHHHCCEE
18.3132142685
773UbiquitinationVVLGLQYLHEHKIVY
HHHHHHHHHHCCEEE
2.1732015554
784UbiquitinationKIVYRDLKLDNLLLD
CEEECCCCCCCEEEC
59.0721906983
792PhosphorylationLDNLLLDTEGFVKIA
CCCEEECCCCCEEHH
37.6727251275
799PhosphorylationTEGFVKIADFGLCKE
CCCCEEHHHCCCCCC
10.6032142685
800PhosphorylationEGFVKIADFGLCKEG
CCCEEHHHCCCCCCC
41.4432142685
801PhosphorylationGFVKIADFGLCKEGM
CCEEHHHCCCCCCCC
6.2632645325
804PhosphorylationKIADFGLCKEGMGYG
EHHHCCCCCCCCCCC
3.7432142685
805UbiquitinationIADFGLCKEGMGYGD
HHHCCCCCCCCCCCC
63.45-
810PhosphorylationLCKEGMGYGDRTSTF
CCCCCCCCCCCCCCC
13.6322322096
814PhosphorylationGMGYGDRTSTFCGTP
CCCCCCCCCCCCCCC
36.5422322096
815PhosphorylationMGYGDRTSTFCGTPE
CCCCCCCCCCCCCCC
22.0022322096
816PhosphorylationGYGDRTSTFCGTPEF
CCCCCCCCCCCCCCC
23.4922322096
820PhosphorylationRTSTFCGTPEFLAPE
CCCCCCCCCCCCCHH
22.3321712546
832PhosphorylationAPEVLTETSYTRAVD
CHHHHCCCCCCCCHH
23.0728985074
834PhosphorylationEVLTETSYTRAVDWW
HHHCCCCCCCCHHHH
13.9928985074
866UbiquitinationGDDEEEVFDSIVNDE
CCCHHHHHHHHHCCC
7.4427667366
868UbiquitinationDEEEVFDSIVNDEVR
CHHHHHHHHHCCCCC
19.5727667366
880UbiquitinationEVRYPRFLSTEAISI
CCCCCCCCCHHHHHH
6.9929967540
882PhosphorylationRYPRFLSTEAISIMR
CCCCCCCHHHHHHHH
31.4220860994
882UbiquitinationRYPRFLSTEAISIMR
CCCCCCCHHHHHHHH
31.4232015554
903PhosphorylationPERRLGASEKDAEDV
HHHCCCCCCCCHHHH
43.3023403867
910PhosphorylationSEKDAEDVKKHPFFR
CCCCHHHHHHCCHHH
7.1932645325
912UbiquitinationKDAEDVKKHPFFRLI
CCHHHHHHCCHHHCC
57.2529967540
914UbiquitinationAEDVKKHPFFRLIDW
HHHHHHCCHHHCCCH
38.6632015554
928UbiquitinationWSALMDKKVKPPFIP
HHHHCCCCCCCCCCC
51.7529967540
930UbiquitinationALMDKKVKPPFIPTI
HHCCCCCCCCCCCCC
56.7232015554
942PhosphorylationPTIRGREDVSNFDDE
CCCCCCCCCCCCCCC
48.0232645325
944PhosphorylationIRGREDVSNFDDEFT
CCCCCCCCCCCCCCC
44.0620873877
951PhosphorylationSNFDDEFTSEAPILT
CCCCCCCCCCCCCCC
24.4923927012
952PhosphorylationNFDDEFTSEAPILTP
CCCCCCCCCCCCCCC
36.7622167270
958PhosphorylationTSEAPILTPPREPRI
CCCCCCCCCCCCCCC
31.7829255136
967PhosphorylationPREPRILSEEEQEMF
CCCCCCCCHHHHHHH
40.3626074081

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
535SPhosphorylationKinaseCDK1P06493
PSP
816TPhosphorylationKinasePDK1Q15118
GPS
816TPhosphorylationKinasePDK1O15530
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PKN2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PKN2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PTN13_HUMANPTPN13physical
11356191
AKT1_HUMANAKT1physical
10926925
RHOA_HUMANRHOAphysical
9446575
PDPK1_HUMANPDPK1physical
10764742
PKN2_HUMANPKN2physical
10818102
HDAC5_HUMANHDAC5physical
20188095
CC136_HUMANCCDC136physical
21900206
SCG1_HUMANCHGBphysical
21900206
MYO9B_HUMANMYO9Bphysical
21900206
F193B_HUMANFAM193Bphysical
21900206
EIF3G_HUMANEIF3Gphysical
21900206
EF1A1_HUMANEEF1A1physical
21900206
GCP60_HUMANACBD3physical
26344197
LSM2_HUMANLSM2physical
26344197
LSM3_HUMANLSM3physical
26344197
LSM4_HUMANLSM4physical
26344197
LSM6_HUMANLSM6physical
26344197
LSM7_HUMANLSM7physical
26344197
PPM1B_HUMANPPM1Bphysical
26344197
RPE_HUMANRPEphysical
26344197
AT2A2_HUMANATP2A2physical
26496610
BTF3_HUMANBTF3physical
26496610
SYDC_HUMANDARSphysical
26496610
EF1D_HUMANEEF1Dphysical
26496610
EF1G_HUMANEEF1Gphysical
26496610
SYEP_HUMANEPRSphysical
26496610
SYIC_HUMANIARSphysical
26496610
SYK_HUMANKARSphysical
26496610
KTN1_HUMANKTN1physical
26496610
SYMC_HUMANMARSphysical
26496610
SYRC_HUMANRARSphysical
26496610
SOAT1_HUMANSOAT1physical
26496610
SYVC_HUMANVARSphysical
26496610
SGPL1_HUMANSGPL1physical
26496610
VAPB_HUMANVAPBphysical
26496610
MCA3_HUMANEEF1E1physical
26496610
ERLN1_HUMANERLIN1physical
26496610
CKAP4_HUMANCKAP4physical
26496610
TRAM1_HUMANTRAM1physical
26496610
SYLC_HUMANLARSphysical
26496610
WDR74_HUMANWDR74physical
26496610
MBOA7_HUMANMBOAT7physical
26496610
TRM1L_HUMANTRMT1Lphysical
26496610
TMUB1_HUMANTMUB1physical
26496610
RABL3_HUMANRABL3physical
26496610

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PKN2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-360 AND SER-583, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-582; SER-583 ANDTHR-814, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-360 AND SER-583, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-110; THR-121; THR-124;SER-302; SER-306; SER-360; SER-362; SER-535; THR-628; SER-631 ANDTHR-958, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-302; SER-306; SER-360;SER-535; SER-583 AND THR-958, AND MASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-360; SER-531 ANDSER-535, AND MASS SPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-531 AND SER-535, ANDMASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-302; SER-306 ANDSER-360, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-289; SER-583 ANDTHR-958, AND MASS SPECTROMETRY.
"Phosphoproteomic analysis of synaptosomes from human cerebralcortex.";
DeGiorgis J.A., Jaffe H., Moreira J.E., Carlotti C.G. Jr., Leite J.P.,Pant H.C., Dosemeci A.;
J. Proteome Res. 4:306-315(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-559 AND SER-561, ANDMASS SPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-582 AND THR-816, ANDMASS SPECTROMETRY.
"Phosphorylation of protein kinase N by phosphoinositide-dependentprotein kinase-1 mediates insulin signals to the actin cytoskeleton.";
Dong L.Q., Landa L.R., Wick M.J., Zhu L., Mukai H., Ono Y., Liu F.;
Proc. Natl. Acad. Sci. U.S.A. 97:5089-5094(2000).
Cited for: PHOSPHORYLATION AT THR-816 BY PDPK1, AND INTERACTION WITH PDPK1.

TOP